☆ 4.5 Article

Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report

FRONTIERS IN PEDIATRICS (2023)

Related references

Note: Only part of the references are listed.

Review Peripheral Vascular Disease

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management

Michael J. Litt et al.

Summary: Hypertrophic cardiomyopathy (HCM) is a common inheritable cardiac disorder, and advances in imaging and genetics have greatly improved our understanding of the disease. A multidisciplinary approach to diagnosis and treatment, along with advancements in medical, percutaneous, and surgical therapies, has led to better outcomes and personalized care for patients with HCM.

VASCULAR HEALTH AND RISK MANAGEMENT (2023)

Add to Collection

Article Medicine, General & Internal

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy

Jie Liu et al.

Summary: This study investigates the characteristics and prognosis of heart failure with preserved ejection fraction (HFpEF) in patients with hypertrophic cardiomyopathy (HCM). The results show that HFpEF patients have greater disease severity and higher mortality than non-HF patients, indicating the need for more aggressive treatment in HF management.

BMC MEDICINE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management of Hypertrophic Cardiomyopathy JACC State-of-the-Art Review

Barry J. Maron et al.

Summary: Hypertrophic cardiomyopathy (HCM), a common and often inherited primary cardiac disease, can be effectively treated with various options that significantly improve patient outcomes. Innovations in risk stratification, surgical intervention, anticoagulation prophylaxis, and ablation techniques have reduced morbidity and mortality rates. Palliative pharmacological strategies can control symptoms in the short-term, but have limited impact on long-term clinical course.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hypertrophic cardiomyopathy in children

Shuiyun Wang et al.

Summary: Hypertrophic cardiomyopathy (HCM) in pediatric patients has diverse etiologies, and the prognosis depends on age and underlying causes. Surgical treatment in experienced tertiary referral centers yields favorable outcomes for children with obstructive HCM, with implantable cardioverter-defibrillator (ICD) being the most effective prevention method for sudden cardiac death (SCD). A new pediatric SCD risk prediction model is expected to be further refined to distinguish patients who would benefit most from an ICD implantation.

ASIAN CARDIOVASCULAR & THORACIC ANNALS (2022)

Add to Collection

Article Genetics & Heredity

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

Andrew R. Harper et al.

Summary: The study identified 12 genome-wide significant susceptibility loci for HCM, showing a strong polygenic influence, especially for sarcomere-negative HCM. A genetic risk score influenced the odds of HCM and phenotypic severity in carriers of sarcomere variants. Mendelian randomization identified diastolic blood pressure as a key modifiable risk factor for sarcomere-negative HCM.

NATURE GENETICS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Molecular Genetic Basis of Hypertrophic Cardiomyopathy

A. J. Marian

Summary: Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by left ventricular hypertrophy and may lead to heart failure or sudden cardiac death. Pathogenic variants in genes encoding myocardial protein constituents, especially MYH7 and MYBPC3 genes, are the main causes of HCM. Advances in genetic testing and drug development have improved the therapeutic prospects for HCM.

CIRCULATION RESEARCH (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation

Heeyoung Seok et al.

Summary: Pediatric hypertrophic cardiomyopathy (HCM) differs from adult HCM in various aspects, with higher mortality rates in infants and adolescents. Non-sarcomeric causes are more common in pediatric HCM. Neonates undergo dynamic changes during transitional circulation, impacting the maturation of cardiomyocytes.

KOREAN CIRCULATION JOURNAL (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

East Asian-Specific Common Variant in TNNI3 Predisposes to Hypertrophic Cardiomyopathy

Guixin Wu et al.

CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Steve R. Ommen et al.

CIRCULATION (2020)

Add to Collection

Article Health Care Sciences & Services

Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life

Erica Zaiser et al.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association

Steven E. Lipshultz et al.

CIRCULATION (2019)

Add to Collection

Editorial Material Medicine, General & Internal

Cardiology: hypertrophic cardiomyopathy

John Firth

CLINICAL MEDICINE (2019)

Add to Collection

Review Medicine, General & Internal

Clinical Course and Management of Hypertrophic Cardiomyopathy

Barry J. Maron

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

Ali J. Marian et al.

CIRCULATION RESEARCH (2017)

Add to Collection

Review Anesthesiology

Hypertrophic Cardiomyopathy: A Review

Nadia Hensley et al.

ANESTHESIA AND ANALGESIA (2015)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Recommendations for the diagnosis and management of hypertrophic cardiomyopathy in 2014

Olivier Dubourg et al.

ARCHIVES OF CARDIOVASCULAR DISEASES (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy

Christopher Semsarian et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Add to Collection

Editorial Material Clinical Neurology

The CARE Guidelines: Consensus-Based Clinical Case Reporting Guideline Development

Joel J. Gagnier et al.

HEADACHE (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy

Elena Biagini et al.

AMERICAN JOURNAL OF CARDIOLOGY (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype

Toru Kubo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Add to Collection

Article Medicine, General & Internal

Prevalence of idiopathic hypertrophic cardiomyopathy in China: A population-based echocardiographic analysis of 8080 adults

YB Zou et al.

AMERICAN JOURNAL OF MEDICINE (2004)

Add to Collection

Article Medicine, General & Internal

The epidemiology of childhood cardiomyopathy in Australia

AW Nugent et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.